Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.
Base excision repair
COVID-19
Mutation
N protein
RNA binding domain
SARS-CoV-2
Thymine DNA glycosylase (TDG)
Zinc
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
06 Jan 2021
06 Jan 2021
Historique:
received:
01
11
2020
accepted:
29
12
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
13
1
2021
Statut:
epublish
Résumé
This study describes the occurrence of a silent mutation in the RNA binding domain of nucleocapsid phosphoprotein (N protein) coding gene from SARS-CoV-2 that may consequence to a missense mutation by onset of another single nucleotide mutation. In the DNA sequence isolated from severe acute respiratory syndrome (SARS-CoV-2) in Iran, a coding sequence for the RNA binding domain of N protein was detected. The comparison of Chinese and Iranian DNA sequences displayed that a thymine (T) was mutated to cytosine (C), so "TTG" from China was changed to "CTG" in Iran. Both DNA sequences from Iran and China have been encoded for leucine. In addition, the second T in "CTG" in the DNA or uracil (U) in "CUG" in the RNA sequences from Iran can be mutated to another C by a missense mutation resulting from thymine DNA glycosylase (TDG) of human and base excision repair mechanism to produce "CCG" encoding for proline, which consequently may increase the affinity of the RNA binding domain of N protein to viral RNA and improve the transcription rate, pathogenicity, evasion from human immunity system, spreading in the human body, and risk of human-to-human transmission rate of SARS-CoV-2.
Identifiants
pubmed: 33407800
doi: 10.1186/s13104-020-05439-x
pii: 10.1186/s13104-020-05439-x
pmc: PMC7787625
doi:
Substances chimiques
Coronavirus Nucleocapsid Proteins
0
Phosphoproteins
0
RNA, Viral
0
nucleocapsid phosphoprotein, SARS-CoV-2
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10Références
Bioinformatics. 2018 Nov 1;34(21):3755-3758
pubmed: 29850778
Front Immunol. 2019 Oct 01;10:2347
pubmed: 31632411
J Virol. 2010 Nov;84(21):11418-28
pubmed: 20719948
Viruses. 2014 Aug 07;6(8):2991-3018
pubmed: 25105276
Viruses. 2012 Jun;4(6):1011-33
pubmed: 22816037
Biol Proced Online. 2020 Apr 21;22:8
pubmed: 32336957
J Thorac Dis. 2013 Aug;5 Suppl 2:S103-8
pubmed: 23977429
Protein Sci. 2018 Jan;27(1):135-145
pubmed: 28884485
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):E838-47
pubmed: 23401522
Diseases. 2016 Jul 25;4(3):
pubmed: 28933406
J Virol. 2010 Feb;84(4):2169-75
pubmed: 19955314
Virology. 2012 Oct 25;432(2):485-94
pubmed: 22832120
J Virol. 2015 Nov;89(22):11383-95
pubmed: 26339053
PLoS Pathog. 2010 Nov 04;6(11):e1001176
pubmed: 21079686
BMJ. 2020 Mar 12;368:m1036
pubmed: 32165426
Adv Virus Res. 2016;96:165-192
pubmed: 27712623
Curr Opin Virol. 2014 Jun;6:55-60
pubmed: 24762977
PLoS Biol. 2015 May 05;13(5):e1002140
pubmed: 25942442
Vaccine. 2015 Dec 8;33(49):6955-66
pubmed: 26603954
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Nucleic Acids Res. 2015 Jan;43(Database issue):D571-7
pubmed: 25428358
Biol Proced Online. 2020 Jun 19;22:11
pubmed: 32572334
J Enzyme Inhib Med Chem. 2016;31(sup4):176-184
pubmed: 27557594
Eur J Biochem. 2003 Oct;270(20):4070-81
pubmed: 14519118
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466